3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 11.2 HKD 10.67% Market Closed
Market Cap: 26.8B HKD

P/OCF
Price to OCF

12.7
Current
7.2
Median
19.4
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
12.7
=
Market Cap
26.8B HKD
/
Operating Cash Flow
2B CNY
Market Cap P/OCF
CN
3SBio Inc
HKEX:1530
26.8B HKD 12.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -228 196.1
US
Abbvie Inc
NYSE:ABBV
329.3B USD 17.5
US
Amgen Inc
NASDAQ:AMGN
155.5B USD 13.5
US
Gilead Sciences Inc
NASDAQ:GILD
131.5B USD 12.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.9B USD -247.5
US
Epizyme Inc
F:EPE
94.1B EUR -493
AU
CSL Ltd
ASX:CSL
119.6B AUD 24.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
62.8B USD 14.2
US
Seagen Inc
F:SGT
39.3B EUR -79.6
NL
argenx SE
XBRU:ARGX
29.8B EUR -131.3

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A